Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 4Lung Neoplasms 3Urogenital Neoplasms 2Leukemia 2Stomach Neoplasms 1Solid Tumors 1Small Cell Lung Carcinoma 1Recurrence 1Recovery 1Ovarian Neoplasms 1Metabolic Diseases 1Leukemia, Myeloid, Acute 1Kidney Neoplasms 1Keratosis, Actinic 1Genital Neoplasms, Male 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Cachexia 1

Interventions

Oxaliplatin 295Capecitabine 209Fluorouracil 183Cisplatin 172Docetaxel 140S 1 (combination) 135Paclitaxel 128Leucovorin 117Irinotecan 110pembrolizumab 104Trastuzumab 76Nivolumab 59apatinib 57Drug Therapy 52sintilimab 46Surgical Procedures, Operative 45Ramucirumab 40Radiotherapy 40Bevacizumab 37Hyperthermic Intraperitoneal Chemotherapy 34Epirubicin 32titanium silicide 31tislelizumab 31Carboplatin 31Gastrectomy 28Cyclophosphamide 27XELOX 25Tegafur 24Folfox protocol 23Albumin-Bound Paclitaxel 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomach Neoplasms × Powders × Clear all
NCT05023499 2021-08-26

Perioperative Glutamine Supplementation and Cachexia

National Taiwan University Hospital

Completed
550 enrolled
Gastrointestinal

Cachexia, Metabolic Diseases, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡